Heart failure & cardiomyopathiesSecondary analysis

Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy

J Am Coll CardiolPublished

  • Secondary analysis of the ATTRibute-CM randomised trial
  • phase 3

Authors' conclusion

Acoramidis-mediated early ΔTTR is independently associated with improved survival after adjusting for known predictors.

Study context

Population
Participants with ATTR-CM from the ATTRibute-CM study population
Participants
557 participants
Comparison
Early change in sTTR with acoramidis and association with all-cause mortality
Primary endpoint
Association of early change in sTTR (day 28) with all-cause mortality
Follow-up
30 months

Primary result

All-cause mortality by early ΔTTR (day 28)

Hazard ratio

0.96

95% CI 0.93–0.98

P = 0.002

Early ΔTTR (per 1 mg/dL increase)
HR 0.96 (95% CI 0.93–0.98); P = 0.002

Per 1 mg/dL increase, as printed

As reported in the abstract

Early ΔTTR independently associated with reduced all-cause mortality in multivariate analysis (adjusted for TTR variant, NYHA class, NAC stage, baseline sTTR)
P < 0.001
Early ΔTTR fully mediates acoramidis effect on all-cause mortality: average causal mediation effect
−0.117
Average direct effect
0.0366
Predicted relative reduction in odds of all-cause mortality per 5 mg/dL increase in sTTR (logistic model)
31.6%

Further findings

Early rise in sTTR with acoramidis within 28 days · 28 days, sustained through 30 months
9.1 · mean · mg/dL

Overall survival by baseline sTTR ≥20 vs <20 mg/dL

Greater overall survival with baseline sTTR ≥20 mg/dL than <20 mg/dL
P < 0.0001

Early ΔTTR and all-cause mortality by treatment

Association with reduced all-cause mortality with acoramidis; no such association with placebo

Original publication

Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy. J Am Coll Cardiol. Published 27 May 2025. doi:10.1016/j.jacc.2025.03.542

Summarised from the published abstract; every number is checked against it